These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 9064352)
1. Constitutive class I-restricted exogenous presentation of self antigens in vivo. Kurts C; Heath WR; Carbone FR; Allison J; Miller JF; Kosaka H J Exp Med; 1996 Sep; 184(3):923-30. PubMed ID: 9064352 [TBL] [Abstract][Full Text] [Related]
2. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. Kurts C; Kosaka H; Carbone FR; Miller JF; Heath WR J Exp Med; 1997 Jul; 186(2):239-45. PubMed ID: 9221753 [TBL] [Abstract][Full Text] [Related]
3. The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). Kurts C; Heath WR; Kosaka H; Miller JF; Carbone FR J Exp Med; 1998 Jul; 188(2):415-20. PubMed ID: 9670055 [TBL] [Abstract][Full Text] [Related]
4. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105 [TBL] [Abstract][Full Text] [Related]
5. Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity. Kurts C; Heath WR; Carbone FR; Kosaka H; Miller JF Novartis Found Symp; 1998; 215():172-81; discussion 181-90. PubMed ID: 9760579 [TBL] [Abstract][Full Text] [Related]
6. Acquired pMHC I complexes greatly enhance CD4(+) Th cell's stimulatory effect on CD8(+) T cell-mediated diabetes in transgenic RIP-mOVA mice. Ahmed KA; Xie Y; Zhang X; Xiang J Cell Mol Immunol; 2008 Dec; 5(6):407-15. PubMed ID: 19118506 [TBL] [Abstract][Full Text] [Related]
7. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes. Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194 [TBL] [Abstract][Full Text] [Related]
8. Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice. Shibaki A; Sato A; Vogel JC; Miyagawa F; Katz SI J Invest Dermatol; 2004 Jul; 123(1):109-15. PubMed ID: 15191550 [TBL] [Abstract][Full Text] [Related]
9. Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration. Kurts C; Klebba I; Davey GM; Koch KM; Miller JF; Heath WR; Floege J Kidney Int; 2001 Aug; 60(2):664-71. PubMed ID: 11473649 [TBL] [Abstract][Full Text] [Related]
10. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues. Keir ME; Freeman GJ; Sharpe AH J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591 [TBL] [Abstract][Full Text] [Related]
11. Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens. Miller AM; Bahmanof M; Zehn D; Cohen EEW; Schoenberger SP Cancer Immunol Res; 2019 Jan; 7(1):40-49. PubMed ID: 30482746 [TBL] [Abstract][Full Text] [Related]
12. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. Li M; Davey GM; Sutherland RM; Kurts C; Lew AM; Hirst C; Carbone FR; Heath WR J Immunol; 2001 May; 166(10):6099-103. PubMed ID: 11342628 [TBL] [Abstract][Full Text] [Related]
13. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116 [TBL] [Abstract][Full Text] [Related]
14. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504 [TBL] [Abstract][Full Text] [Related]
15. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889 [TBL] [Abstract][Full Text] [Related]
16. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model. Liao H; Franck E; Fréret M; Adriouch S; Baba-Amer Y; Authier FJ; Boyer O; Gherardi RK Arthritis Rheum; 2012 Oct; 64(10):3441-51. PubMed ID: 22674045 [TBL] [Abstract][Full Text] [Related]
17. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Na SY; Cao Y; Toben C; Nitschke L; Stadelmann C; Gold R; Schimpl A; Hünig T Brain; 2008 Sep; 131(Pt 9):2353-65. PubMed ID: 18669487 [TBL] [Abstract][Full Text] [Related]
18. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. Grabie N; Delfs MW; Westrich JR; Love VA; Stavrakis G; Ahmad F; Seidman CE; Seidman JG; Lichtman AH J Clin Invest; 2003 Mar; 111(5):671-80. PubMed ID: 12618521 [TBL] [Abstract][Full Text] [Related]
19. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene. Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163 [TBL] [Abstract][Full Text] [Related]
20. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation. Kezuka T; Streilein JW Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]